Bulletin
Investor Alert

New York Markets Open in:

Repligen Corp.

NAS: RGEN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/210324360/composite

$

186.75

Change

-0.36 -0.19%

Volume

Volume 23,282

Sep 30, 2022, 6:17 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/210324360/composite

Previous close

$ 191.06

$ 187.11

Change

-3.95 -2.07%

Day low

Day high

$186.60

$193.91

Open
Open: 191.15

52 week low

52 week high

$137.21

$306.98

Open

Market cap

$10.38B

Average volume

531,816

P/E ratio

67.65

Rev. per Employee

$420,502

EPS

2.77

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rgen

MarketWatch News on RGEN

  1. 10 Stocks Driving the Biotech Resurgence

    8:49 a.m. Aug. 18, 2022

    - Barron's Online

  2. Repligen stock price target raised to $275 from $213 at UBS

    8:54 a.m. Aug. 5, 2022

    - Tomi Kilgore

  3. Repligen started at buy with $213 stock price target at UBS

    9:20 a.m. July 20, 2022

    - Tomi Kilgore

  4. Repligen stock price target cut to $230 from $320 at Stifel Nicolaus

    9:01 a.m. Feb. 18, 2022

    - Tomi Kilgore

  5. Repligen stock price target raised to $335 from $255 at KeyBanc Capital

    6:15 a.m. Sept. 17, 2021

    - Tomi Kilgore

  6. How a 53-Year-Old Growth Fund Takes the Long View

    3:05 p.m. Nov. 29, 2021

    - Barron's Online

  7. Repligen started at overweight with $241 stock price target at KeyBanc Capital

    8:03 a.m. Nov. 10, 2020

    - Tomi Kilgore

  8. Small-Cap ‘Darlings’ Are Perking Up in 2020

    11:47 a.m. Jan. 21, 2020

    - Barron's Online

  9. These 6 stocks in the S&P 1500 have more than doubled in 12 months

    7:28 a.m. July 13, 2019

    - Philip van Doorn

  10. Repligen started at overweight with $42 stock price target at J.P. Morgan

    8:28 a.m. Dec. 5, 2017

    - Tomi Kilgore

  11. Repligen stock fair value estimate raised to $47 from $42 at Janney

    11:26 a.m. June 23, 2017

    - Tomi Kilgore

  12. Repligen agrees to buy Spectrum in a cash-and-stock deal valued at $359 mln

    7:01 a.m. June 23, 2017

    - Tomi Kilgore

  13. Repligen's stock halted for news pending

    6:58 a.m. June 23, 2017

    - Tomi Kilgore

  14. Repligen's stock was inactive premarket prior to trading halt

    6:59 a.m. June 23, 2017

    - Tomi Kilgore

  15. Investing From the Ground Up

    12:13 a.m. Sept. 15, 2016

    - Barron's Online

  16. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/rgen

Other News on RGEN

  1. Repligen: Now Best Biotech Nearby Cap-Gain Prospect

    11:44 a.m. Sept. 27, 2022

    - Seeking Alpha

  2. Repligen partners with DRS daylight solutions

    4:12 p.m. Sept. 19, 2022

    - Seeking Alpha

  3. Checking In on 10 Stock Picks

    10:00 a.m. Sept. 17, 2022

    - Motley Fool

  4. 2 Top Healthcare Stocks to Buy for September

    10:15 a.m. Sept. 8, 2022

    - Motley Fool

  5. These 3 Stocks Are the Future of Biotechnology

    10:36 a.m. Sept. 4, 2022

    - Motley Fool

  6. Bruker Corporation: Upside Is Limited From Here

    3:01 p.m. Aug. 24, 2022

    - Seeking Alpha

  7. Here's Why Repligen (RGEN) is a Strong Growth Stock

    9:45 a.m. Aug. 17, 2022

    - Zacks.com

  8. Top 5 2nd Quarter Trades of BROWN CAPITAL MANAGEMENT LLC

    3:00 p.m. Aug. 15, 2022

    - GuruFocus.com

  9. Repligen gains after report of rejected takeover offer (update)

    4:42 p.m. Aug. 11, 2022

    - Seeking Alpha

  10. Why Shares of Repligen Surged This Week

    1:57 p.m. Aug. 4, 2022

    - Motley Fool

  11. Why Repligen Corporation Stock Is Storming Higher Today

    2:56 p.m. Aug. 2, 2022

    - Motley Fool

  12. Repligen surges 11% as it raises fiscal 2022 financial guidance

    11:23 a.m. Aug. 2, 2022

    - Seeking Alpha

  13. Repligen (RGEN) Tops Q2 Earnings and Revenue Estimates

    8:45 a.m. Aug. 2, 2022

    - Zacks.com

  14. Repligen Q2 2022 Earnings Preview

    12:58 p.m. Aug. 1, 2022

    - Seeking Alpha

  15. Notable earnings before Tuesday's open

    10:59 a.m. Aug. 1, 2022

    - Seeking Alpha

  16. Loading more headlines...
/news/pressrelease/company/us/rgen

Press Releases on RGEN

  1. Repligen To Host Investor Day 2022

    7:30 a.m. Aug. 24, 2022

    - GlobeNewswire

  2. Tuesday's ETF with Unusual Volume: EPS

    12:27 p.m. Aug. 2, 2022

    - MarketNewsVideo.com

  3. Repligen to Report Second Quarter 2022 Financial Results

    7:30 a.m. July 19, 2022

    - GlobeNewswire

  4. Repligen to Report First Quarter 2022 Financial Results

    7:30 a.m. April 13, 2022

    - GlobeNewswire

  5. Regeneron Drug Could be Less Effective vs. Omicron

    11:12 a.m. Nov. 30, 2021

    - Baystreet.ca

  6. IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS

    8:26 p.m. Nov. 11, 2021

    - GlobeNewswire

  7. Repligen Releases Inaugural Sustainability Report

    8:00 a.m. Nov. 5, 2021

    - GlobeNewswire

  8. Loading more headlines...

Rates »

Link to MarketWatch's Slice.